Consent Decree Tempers J&J Consumer Outlook Even As Remediation Ends
This article was originally published in The Pink Sheet Daily
Executive Summary
CFO Dominic Caruso says the firm is more consistent with distributing previously recalled OTCs. U.S. OTC sales jumped 10.7% and “steady progress” is anticipated when the firm completes its remediation responsibilities under a consent decree with FDA.